Protect Pharmaceutical (Protect Pharmaceutical) EV-to-EBIT : -3,277.00 (As of Apr. 28, 2024)

Protect Pharmaceutical EV-to-EBIT Chart

Protect Pharmaceutical Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
EV-to-EBIT		Get a 7-Day Free Trial				-83.29	-239.97	-21.48	-26.43	-8.60

Protect Pharmaceutical Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
EV-to-EBIT	Get a 7-Day Free Trial															-8.77	-6.97	-8.60	-8.23	-1,065.18

Competitive Comparison of Protect Pharmaceutical's EV-to-EBIT

For the Conglomerates subindustry, Protect Pharmaceutical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Protect Pharmaceutical's EV-to-EBIT Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Protect Pharmaceutical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Protect Pharmaceutical's EV-to-EBIT falls into.

Protect Pharmaceutical EV-to-EBIT Calculation

Protect Pharmaceutical's EV-to-EBIT for today is calculated as:

Protect Pharmaceutical's current Enterprise Value is $3.28 Mil.
Protect Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Protect Pharmaceutical  (OTCPK:PRTT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Protect Pharmaceutical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2018 is calculated as:

Protect Pharmaceutical's Enterprise Value for the quarter that ended in Jun. 2018 was $0.89 Mil.
Protect Pharmaceutical's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Protect Pharmaceutical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Protect Pharmaceutical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Protect Pharmaceutical (Protect Pharmaceutical) Business Description